Clinical Outcomes of Patients With Advanced Gastrointestinal Stromal Tumors: Safety and Efficacy in a Worldwide Treatment-Use Trial of Sunitinib

Creative Commons License

Reichardt P., Kang Y., Rutkowski P., Schuette J., Rosen L. S., Seddon B., ...Daha Fazla

CANCER, cilt.121, sa.9, ss.1405-1413, 2015 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 121 Sayı: 9
  • Basım Tarihi: 2015
  • Doi Numarası: 10.1002/cncr.29220
  • Dergi Adı: CANCER
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.1405-1413
  • Hacettepe Üniversitesi Adresli: Evet

Özet

BACKGROUNDThe objectives of this study were to provide sunitinib to patients with gastrointestinal stromal tumor (GIST) who were otherwise unable to obtain it and to collect broad safety and efficacy data from a large population of patients with advanced GIST after imatinib failure.